| ZVRA Shares Outstanding History Table | ||||||||||||||||||||||||||
Below is a table of the ZVRA shares outstanding history going back to 8/11/2023:
Also see: ZVRA Market Cap History ZVRA YTD Return |
ZVRA Shares Outstanding History — Zevra Therapeutics Share Count Over Time
As of 5/1/2026 Zevra Therapeutics has 59.12 million ZVRA shares outstanding. Investors often track the ZVRA shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ZVRA share count trends over time, with 12 historical shares outstanding datapoints presented, dating back to 8/11/2023.
| ZVRA Shares Outstanding History Chart | |||||||||||||||||||||||||||
ZVRA Historical Shares Outstanding: +22.61% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||
| ZVRA Stock Price Chart |
| About Zevra Therapeutics, Inc |
| Zevra Therapeutics, Inc. is a rare disease company science, data, and patients need to create transformational therapies for diseases with limited or no treatment options. Co. has a diverse portfolio of products and product candidates, which includes a combination of both a clinical stage pipeline and commercial stage assets. Its pipeline includes arimoclomol, an orally delivered, investigational product candidate being developed for Niemann-Pick disease type C (NPC). KP1077 is the Co.'s lead clinical development product candidate which is being developed as a treatment for idiopathic hypersomnia (IH), a rare neurological sleep disorder, and narcolepsy. We show 12 historical shares outstanding datapoints in our coverage of ZVRA's shares outstanding history. Understanding the changing numbers of ZVRA shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ZVRA versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ZVRA by allowing them to research ZVRA shares outstanding history as well as any other stock in our coverage universe. |
| ZVRA Current Stock Quote |
Quotes delayed 20 minutes  Free ZVRA Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| ZVRA Share Performance |
| Shares Outstanding Peers |
| Zevra Therapeutics (ZVRA) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ZVSA Shares Outstanding History ZY Shares Outstanding History ZYME Shares Outstanding History ZYNE Shares Outstanding History ZYXI Shares Outstanding History A Shares Outstanding History AAC Shares Outstanding History AADI Shares Outstanding History AARD Shares Outstanding History ABAX Shares Outstanding History More Healthcare companies » |
ZVRA Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
